The US approved a new Covid-19 vaccine created by Moderna Late Friday but with limits Who can use it – not a replacement for existing company shooting, but the second option.
The new vaccine, Muxspike, is a step towards the new generation coronavirus vaccines. It is produced in a manner that allows a lower dose of the dose of its current COVID-19 vaccine, a spikevax-resident by its immune goal.
Approval “adds an important new tool that helps protect people with a high risk of serious illness from COVID-19,” said Stephane Bancel, CEO of Modernism on Saturday.
Food and drug management approved a new vaccine for use in all adults 65 and elderly and for people aged 12 to 64 years of age who have at least one health condition that exposes them to an increased risk of coronavirus.
This is the same limit set by the FDA licensing another option for the COVID-19 vaccine from a competitor Novavax.
These restrictions are diverting from how the US has so far treated Covid-19 vaccines, reflecting Skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. And other Trump officials.
The existing vaccine of modern modernism must not face these limits and has long been used for anyone at the age of 6 months and older. The company said it expects to offer both options this autumn.
The FDA approval was based on a study aged 11,400 people aged 12 and older, which compared a new low dose vaccine with an existing modern vaccine. She found that the new vaccine was safe and at least equally effective – and more according to some measures – than the original shot, the company said.
News came only a few days after Trump’s administration canceled financing For modern developing vaccines against potential pandemic influenza viruses, including H5N1 bird flu, despite the promising results of early studies.
The Health and Science Department of Associated Press receives support from the group of scientific and educational media Howard Hughes Medical Institute and Foundation Robert Wood Johnson. AP is exclusively responsible for all content.
(Tagstotranslate) COVID-19 Vaccine
